XENE: Xenon Pharmaceuticals Inc. Bozor kapitallashuvining daromadga nisbati
Ion kanallaridagi innovatsiyalar va Azetukalner dvorisining muvaffaqiyati Xenon Pharmaceuticals (XENE) o'sishini ta'minlamoqda. Kompaniyaning normallashtirilgan P/S koeffitsiyenti biznesning daromadga nisbatan baholanishini aks ettiradi, 710.90 esa yangi darajani belgilaydi. Yagona asosiy mahsulotga yuqori bog'liqlik biotexnologik xatarlarni yuzaga keltiradi. Yakuniy nuqtada, kompaniya og'ir nevrologik patologiyalar uchun ilg'or davolash tizimini ishlab chiqmoqda.
Xenon Corp (XENE) kompaniyasining tahliliy kesimlari
- aksiya kursi va ekspertlarning narx prognozi:
- bozor kapitallashuvi haqida ma'lumot:
- balans kapitallashuvi ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning xususiy kapitalga nisbati Xenon Pharmaceuticals|XENE - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Xenon Pharmaceuticals|XENE - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati Xenon Corp|XENE - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Xenon Pharmaceuticals|Tezkor likvidlik koeffitsiyenti xenon-pharma.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
XENE - Sof daromad|Kelajakdagi sof foyda Xenon Pharmaceuticals|XENE - P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Xenon Pharmaceuticals Inc|XENE - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Xenon Corp|XENE - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Xenon Pharmaceuticals|XENE - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi xenon-pharma.com|XENE - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Xenon Pharmaceuticals
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning umumiy tahlili:XENE (Xenon)
P/S koeffitsienti Xenon Pharmaceuticals (XENE) kompaniyasining bozor qiymatini uning yillik daromadiga nisbatan baholaydi, bu esa investorlarga sotuvlarning har bir birligi uchun to'langan premiumni aniqlash imkonini beradi. P/S qiymatlarining tarixini tahlil qilish orqali, bunda joriy daraja 710.90 ni tashkil etadi, kapitalizatsiyani neyro-tadqiqotlar uchun moddalar logistikasining samaradorligi bilan bog'lash mumkin, uning yetkazib berish protokollarining uzluksizligi va qat'iy amal qilinishi kompaniyaning pul oqimining fundamental asosini tashkil etadi.
Raqobatdosh kompaniyalar
BIIB (Biogen) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NBIX (Neurocrine Corp)|Regencell Bioscience - Narxning daromadga nisbati|Axsome Therapeutics - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ACAD (ACADIA Pharmaceuticals)|VKTX: P/S multiplikatori|Narxning sotuvga nisbati SUPN (Supernus)|CPRX (Catalyst Pharmaceuticals Inc) - P/S multiplikatori|DNLI: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati harmonybiosciences.com (HRMY)|Biohaven - Kapitalizatsiya va daromad nisbati|P/S multiplikatori AMLX (amylyx.com)|Trevi Pharma (TRVI) - Sotuvga nisbatan narx|Praxis Corp - P/S multiplikatori|Anavex Corp (AVXL) - Kapitalizatsiyaning daromadga nisbati|CBLL: P/S multiplikatori|Prothena Biosciences - Bozor kapitallashuvining daromadga nisbati|ALEC (alector.com) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati ANNX (Annexon Biosciences)|Narxning daromadga nisbati Omeros Corporation (OMER)|Neurogene Corp - Kapitalizatsiya va daromad nisbati|Narxning daromadga nisbati AC Immune S.A. ACIU|Narx/daromad koeffitsiyenti Voyager Therapeutics (VYGR)|Neumora - P/S multiplikatori|Narxning sotuvga nisbati SCLX|Tevogen Bio Inc. (TVGN) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati ACOG|CGTX (cogrx.com) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati inhibikase.com (IKT)|Narxning daromadga nisbati Cassava Sciences Inc (SAVA)|Narx/daromad koeffitsiyenti Assertio|P/S multiplikatori COYA (Coya Therapeutics, Inc.)|Kapitalizatsiyaning sotish hajmiga nisbati VTGN (VistaGen Therapeutics Inc)|OVID: Kapitalizatsiyaning daromadga nisbati|ABOS: Narxning daromadga nisbati|CervoMed (CRVO) - Narxning daromadga nisbati|Sotuvga nisbatan narx Alterity Therapeutics Ltd (ATHE)|CLNN (Clene) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati PEPG (PepGen)|Kapitalizatsiyaning daromadga nisbati JUNS (Jupiter Neurosciences, Inc.)|P/S multiplikatori relmada.com (RLMD)|Narxning daromadga nisbati Annovis Bio Corp ANVS|GRCE: Kapitalizatsiya va daromad nisbati|AIFF - Narxning daromadga nisbati|KLTO (anewmeds.com) - Kapitalizatsiya va daromad nisbati|NRSN (NeuroSense Therapeutics Ltd.) - Kapitalizatsiyaning daromadga nisbati|revivapharma.com - Bozor kapitallashuvining daromadga nisbati|MTVA (metaviatx.com) - P/S multiplikatori|NRXS: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori HSDT|PASG - Sotuvga nisbatan narx|P/S multiplikatori NEUP (Neuphoria Therapeutics)|NERV: Kapitalizatsiya va daromad nisbati|ATHA: Kapitalizatsiyaning daromadga nisbati|Addex Therapeutics Ltd - Kapitalizatsiyaning sotish hajmiga nisbati|Alzamend Neuro, Inc. (ALZN) - Narxning daromadga nisbati|CYCN (Cyclerion Therapeutics Inc.) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati PTIX|KTTA: Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati CRGT (Cortigent Medical)|ATXI (Avenue Therapeutics, Inc.) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|Bozor kapitallashuvining daromadga nisbati CARA|chromocell.com - P/S multiplikatori|Narxning sotuvga nisbati ELYM|ITCI: P/S multiplikatori|Sotuvga nisbatan narx Longboard Pharmaceuticals, Inc. (LBPH)|Narxning daromadga nisbati Marinus Pharmaceuticals, Inc.|NKGN: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NRBO|SAGE: Narxning sotuvga nisbati|Synaptogenix Inc. - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati TRVN (Trevena Inc.)|Vigil Neuroscience, Inc. - P/S multiplikatori|Anew Medical (WENA) - Kapitalizatsiyaning daromadga nisbati|CERE (Cerevel Corp) - Kapitalizatsiyaning daromadga nisbati
